Blackwell T K, Huang J, Ma A, Kretzner L, Alt F W, Eisenman R N, Weintraub H
Division of Basic Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington 98104.
Mol Cell Biol. 1993 Sep;13(9):5216-24. doi: 10.1128/mcb.13.9.5216-5224.1993.
Using an in vitro binding-site selection assay, we have demonstrated that c-Myc-Max complexes bind not only to canonical CACGTG or CATGTG motifs that are flanked by variable sequences but also to noncanonical sites that consist of an internal CG or TG dinucleotide in the context of particular variations in the CA--TG consensus. None of the selected sites contain an internal TA dinucleotide, suggesting that Myc proteins necessarily bind asymmetrically in the context of a CAT half-site. The noncanonical sites can all be bound by proteins of the Myc-Max family but not necessarily by the related CACGTG- and CATGTG-binding proteins USF and TFE3. Substitution of an arginine that is conserved in these proteins into MyoD (MyoD-R) changes its binding specificity so that it recognizes CACGTG instead of the MyoD cognate sequence (CAGCTG). However, like USF and TFE3, MyoD-R does not bind to all of the noncanonical c-Myc-Max sites. Although this R substitution changes the internal dinucleotide specificity of MyoD, it does not significantly alter its wild-type binding sequence preferences at positions outside of the CA--TG motif, suggesting that it does not dramatically change other important amino acid-DNA contacts; this observation has important implications for models of basic-helix-loop-helix protein-DNA binding.
通过体外结合位点筛选试验,我们已经证明,c-Myc-Max复合物不仅能结合两侧带有可变序列的典型CACGTG或CATGTG基序,还能结合在CA--TG共有序列特定变异情况下由内部CG或TG二核苷酸组成的非典型位点。所有筛选出的位点均不包含内部TA二核苷酸,这表明Myc蛋白在CAT半位点的情况下必然以不对称方式结合。非典型位点都能被Myc-Max家族的蛋白质结合,但不一定能被相关的CACGTG和CATGTG结合蛋白USF和TFE3结合。将这些蛋白质中保守的精氨酸替换到MyoD中(MyoD-R)会改变其结合特异性,使其识别CACGTG而非MyoD的同源序列(CAGCTG)。然而,与USF和TFE3一样,MyoD-R并不结合所有非典型的c-Myc-Max位点。虽然这种R替换改变了MyoD的内部二核苷酸特异性,但它并没有显著改变其在CA--TG基序之外位置的野生型结合序列偏好,这表明它并没有显著改变其他重要的氨基酸与DNA的接触;这一观察结果对碱性螺旋-环-螺旋蛋白与DNA结合的模型具有重要意义。